Mr. Clancy has served as a member of our board of directors since September 2013. Mr. Clancy has more than 30 years of experience in financial management and strategic business planning, and served as chief financial officer at Alexion Pharmaceuticals until December 2019. Prior to Alexion, he served as the executive vice president and chief financial officer at Biogen Inc. (formerly Biogen Idec) for 10 years. He also served as senior vice president of finance for Biogen Idec, with responsibilities for leading the treasury, tax, investor relations and business planning groups. Prior to the merger of Biogen and Idec, Mr. Clancy was the vice president of portfolio management at Biogen Inc. He joined the company in 2001 as vice president of U.S. marketing. Before Biogen Inc., Mr. Clancy spent 13 years at PepsiCo, serving in a variety of financial and general management positions, including vice president and general manager of their Great West Business Unit. Mr. Clancy is a member of the Board of Directors of Incyte Corporation. Mr. Clancy has an MBA from Columbia Business School in New York City and received his B.S. in business administration from Babson College in Wellesley, Mass.